首页    期刊浏览 2024年07月21日 星期日
登录注册

文章基本信息

  • 标题:CRISPR-based technology to silence the expression of IncRNAs
  • 本地全文:下载
  • 作者:James D. Phelan ; Louis M. Staudt
  • 期刊名称:Proceedings of the National Academy of Sciences
  • 印刷版ISSN:0027-8424
  • 电子版ISSN:1091-6490
  • 出版年度:2020
  • 卷号:117
  • 期号:15
  • 页码:8225-8227
  • DOI:10.1073/pnas.2003702117
  • 出版社:The National Academy of Sciences of the United States of America
  • 摘要:The human genome contains more than 3 billion base pairs, and some estimates suggest that nearly 75% of the genome may be transcribed (1), yet only a small fraction (1 to 2%) of the genome that encodes for protein coding regions has been systematically probed for function. The transcribed genome consists of both short noncoding RNAs (ncRNAs) and long ncRNAs (lncRNAs). The lncRNAs are defined as being greater than 200 nucleotides in length and may be capped, polyadenylated, and spliced like protein-coding genes. By definition, lncRNAs do not contain open reading frames of greater than 50 amino acids, but recent work has uncovered a new world of smaller “microproteins” that are encoded by lncRNAs (2). Other functions of lncRNAs include their ability to form aptamers, which bind and regulate protein complexes (3). The lncRNAs can modulate gene expression by enhancer trapping (4), and by recruiting histone modifiers to chromatin (5, 6). These examples notwithstanding, the function of most lncRNAs is unknown. In PNAS, Raffeiner et al. (7) develop CRISPR-based technology to silence the expression of lncRNAs, and use their technology to identify functional lncRNAs that are regulated by the oncogene MYC. Recent efforts to identify functional lncRNAs have relied on CRISPR technology, which can exquisitely target CRISPR-associated (Cas) proteins to specific genomic locations. This technology has ushered in a new era of functional genomics in which large-scale screens have exponentially increased our understanding of complex genotype−phenotype relationships (8⇓–10). CRISPR-Cas9 pooled screens have become a mainstay of cancer research (11, 12), revealing gene essentiality, synthetic lethality, and mechanisms of resistance to targeted therapy and immunotherapy, among countless other phenotypes. Most of these screens have relied on Cas9-induced DNA double-stranded … [↵][1]1To whom correspondence may be addressed. Email: lstaudt{at}mail.nih.gov. [1]: #xref-corresp-1-1
国家哲学社会科学文献中心版权所有